AstraZeneca PLC
AZNNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Score 12/30
$163.95−1.46 (-0.88%)
Close on Oct 19, 2026Market cap $255.76BP/E 25.1Yield 1.91%
AstraZeneca Lokelma (sodium zirconium cyclosilicate) by Year
Lokelma (sodium zirconium cyclosilicate) — US YoY (%) (%)
AstraZeneca Lokelma (sodium zirconium cyclosilicate): 18.0% in FY2025, down 2.0 pts from a year earlier.
Latest, FY2025
18.0%
Period ended Dec 31, 2025
Change on a year earlier
-2.0 pts
20.0% in FY2024
History
4 years
Since FY2022
Sources
4
Documents cited below
Where the FY2025 figure comes from
“|| Lokelma | 698 | 29 | 28 | 301 | 18 | 129 | 50 | 52 | 129 | 39 | 34 | 139 | 29 | 28”
Source: Form 6-K FY2025Q4 Earnings Release ↗
Reported in Form 6-K / 20-F Product Sales Table.
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Lokelma (sodium zirconium cyclosilicate) — US YoY (%) (%) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 18.0% | -2.0 pts | Form 6-K FY2025Q4 Earnings Release ↗ |
| FY2024 | Dec 31, 2024 | 20.0% | -6.0 pts | Form 6-K FY2024Q4 Earnings Release ↗ |
| FY2023 | Dec 31, 2023 | 26.0% | -21.0 pts | Form 6-K FY2023Q4 Earnings Release ↗ |
| FY2022 | Dec 31, 2022 | 47.0% | – | Form 6-K FY2022Q4 Earnings Release ↗ |
Cite this data
StockData. (2026). AstraZeneca Lokelma (sodium zirconium cyclosilicate) (%), annual FY2022–FY2025 [Data set]. Compiled from AstraZeneca SEC filings and investor materials. https://stockdatahq.com/stocks/azn/kpis/med-lokelma-us-yoy
See every metric in the AstraZeneca KPI table. Data updated Oct 28, 2026.
See a number that looks wrong?